Medicinehospital

Infliximab

An anti-TNF antibody infusion for Crohn's disease, ulcerative colitis, arthritis and psoriasis.

Clinical information

Common uses

Crohn's disease and ulcerative colitis
rheumatoid and psoriatic arthritis
ankylosing spondylitis
severe plaque psoriasis

Common side effects

infections such as sinus and throat infections
infusion-related reactions
headache
stomach pain

Cautions

serious infections including TB — TB test before starting
lymphoma and other cancers reported
can worsen heart failure
avoid live vaccines

Interactions

other biologic medicines (higher infection risk)
live vaccines (avoid)

Pregnancy: no clear risk seen in studies

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Avsola (infliximab-axxq) label, setid de34bcb7-b524-45c8-9181-61c6f48d540e (accessed 2026-08-16)

Approved brands & formulations1

Brand name	Dosage form	Strength	Importer	Category
Infliximab	Parenteral ( Injection )	100 mg/20 ml	MFDA designated importers with Pre Authorization approval before import	hospital